---
title: bit.bio CEO featured on the Hightech Ventures podcast
description: They ask about reprogramming cells and how the company is aiming to develop cell therapies.
---

[News | bit.bio ](https://www.bit.bio/news)

# [bit.bio CEO featured on the Hightech Ventures podcast](https://www.bit.bio/news/hightech-ventures-podcast)

 Written by [Hightech Ventures](https://www.bit.bio/news/author/hightech-ventures) | Mar 17, 2022 12:00:00 AM

bit.bio CEO Dr Mark Kotter was the interviewee on the March 2022 edition of the Hightech Ventures Podcast. He talks about his ground breaking research and the new opportunities that the phase shift of biology brings to engineering. 

He shares his journey from neurosurgeon to stem cell researcher, to company founder and how our [opti-ox™](https://www-bit-bio.sandbox.hs-sites.com/platform) technology was discovered, what bit.bio hopes to do with human cells and how we’re also supporting [Meatable](https://www.meatable.com/) with opti-ox to create cultured meat.

 

[View full post](https://www.bit.bio/news/hightech-ventures-podcast)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Hightech Ventures"
  },
  "dateModified" : "2022-09-06T20:13:27.205Z",
  "datePublished" : "2022-03-17T00:00:00Z",
  "headline" : "bit.bio CEO featured on the Hightech Ventures podcast",
  "image" : {
    "@type" : "ImageObject",
    "height" : 755,
    "url" : "https://14527135.fs1.hubspotusercontent-na1.net/hubfs/14527135/Imported_Blog_Media/resized%20Dry%20ice%20for%20keeping%20samples%20cold%20%281%29.png",
    "width" : 1200
  },
  "mainEntityOfPage" : "https://www.bit.bio/news/hightech-ventures-podcast",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```